￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Afatinib approval and marketing status and domestic usage guidelines

2026-02-01 22:25:32

Check Details
Evaluation of dependence and long-term use safety of DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Detailed introduction to the indications and treatment scope of Lynparza

2026-02-01 22:25:32

Check Details
Venetoclax medical insurance reimbursement scope and patients’ actual reimbursement amount

2026-02-01 22:25:32

Check Details
Instructions for use of Asnib/Asiminib and patient medication guidelines

2026-02-01 22:25:32

Check Details
How long does it take to see the obvious therapeutic effect of ritexitinib?

2026-02-01 22:25:32

Check Details
How long does it take to take sparsentan (sparsentan) to take effect and recommended course of treatment

2026-02-01 22:25:32

Check Details
Ixazomib (Enleri) dosage, usage and individualized dosage adjustment recommendations

2026-02-01 22:25:32

Check Details
How long does a course of rubitin/rubicatin (Zanbiga) take and what precautions should be taken

2026-02-01 22:25:32

Check Details
Discussion on the clinical application effect of F/TAF blocking drugs and whether they are worthy of long-term use

2026-02-01 22:25:32

Check Details
Is Febuxostat an imported drug or a domestic drug? Differences and buying advice

2026-02-01 22:25:32

Check Details
Whether furmonertinib has been included in medical insurance and interpretation of medical insurance policies

2026-02-01 22:25:32

Check Details
Category
相关知识